Chuck Royce's BVS Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 1.25 M shares of Bioventus Inc. (BVS) worth $9.31 M, representing 0.09% of the portfolio. First purchased in 2021-Q4, this medium-term investment has been held for 15 quarters.
Based on 13F filings, Chuck Royce has maintained a strategic position in BVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 697,696 shares. Largest reduction occurred in Q4 2022, reducing 1.85 M shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Bioventus (BVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bioventus (BVS) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -11,694 | Reduce 0.93% | 1.25 M | $7.44 |
| Q3 2025 | +170,900 | Add 15.65% | 1.26 M | $6.69 |
| Q2 2025 | +199,860 | Add 22.40% | 1.09 M | $6.62 |
| Q1 2025 | +159,980 | Add 21.85% | 892,216 | $9.15 |
| Q4 2024 | +34,540 | Add 4.95% | 732,236 | $10.50 |
| Q3 2024 | +697,696 | New Buy | 697,696 | $11.95 |
| Q4 2023 | -50,000 | Sold Out | 0 | $0.00 |
| Q1 2023 | -191,306 | Reduce 79.28% | 50,000 | $1.07 |
| Q4 2022 | -1.85 M | Reduce 88.49% | 241,306 | $2.61 |
| Q3 2022 | +137,400 | Add 7.01% | 2.1 M | $7.00 |
| Q2 2022 | +15,602 | Add 0.80% | 1.96 M | $6.82 |
| Q1 2022 | +154,978 | Add 8.67% | 1.94 M | $14.10 |
| Q4 2021 | +1.79 M | New Buy | 1.79 M | $14.49 |
Chuck Royce's Bioventus Investment FAQs
Chuck Royce first purchased Bioventus Inc. (BVS) in Q4 2021, acquiring 1,788,205 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Bioventus Inc. (BVS) for 15 quarters since Q4 2021.
Chuck Royce's largest addition to Bioventus Inc. (BVS) was in Q4 2021, adding 1,788,205 shares worth $25.91 M.
According to the latest 13F filing for Q4 2025, Chuck Royce's firm, Royce & Associates Lp, owns 1,251,282 shares of Bioventus Inc. (BVS), valued at approximately $9.31 M.
As of the Q4 2025 filing, Bioventus Inc. (BVS) represents approximately 0.09% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Bioventus Inc. (BVS) was 2,096,185 shares, as reported at the end of Q3 2022.